FOLD logo

Amicus Therapeutics (FOLD) Depreciation and amortization

annual D&A:

$8.55M+$674.00K(+8.56%)
December 31, 2024

Summary

  • As of today (June 2, 2025), FOLD annual depreciation & amortization is $8.55 million, with the most recent change of +$674.00 thousand (+8.56%) on December 31, 2024.
  • During the last 3 years, FOLD annual D&A has risen by +$2.34 million (+37.66%).
  • FOLD annual D&A is now -3.38% below its all-time high of $8.85 million, reached on December 31, 2020.

Performance

FOLD Depreciation and amortization Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherFOLDincome statement metrics

quarterly D&A:

$1.84M-$204.00K(-10.00%)
March 31, 2025

Summary

  • As of today (June 2, 2025), FOLD quarterly depreciation & amortization is $1.84 million, with the most recent change of -$204.00 thousand (-10.00%) on March 31, 2025.
  • Over the past year, FOLD quarterly D&A has dropped by -$317.00 thousand (-14.72%).
  • FOLD quarterly D&A is now -27.88% below its all-time high of $2.55 million, reached on December 31, 2020.

Performance

FOLD quarterly D&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherFOLDincome statement metrics

TTM D&A:

$8.23M-$317.00K(-3.71%)
March 31, 2025

Summary

  • As of today (June 2, 2025), FOLD TTM depreciation & amortization is $8.23 million, with the most recent change of -$317.00 thousand (-3.71%) on March 31, 2025.
  • Over the past year, FOLD TTM D&A has dropped by -$540.00 thousand (-6.16%).
  • FOLD TTM D&A is now -6.96% below its all-time high of $8.85 million, reached on December 31, 2020.

Performance

FOLD TTM D&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherFOLDincome statement metrics

FOLD Depreciation and amortization Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+8.6%-14.7%-6.2%
3 y3 years+37.7%+30.2%+36.8%
5 y5 years+79.0%+4.1%+48.3%

FOLD Depreciation and amortization Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+60.0%-17.6%+46.1%-6.2%+58.6%
5 y5-year-3.4%+79.0%-27.9%+46.1%-7.0%+58.6%
alltimeall time-3.4%+1180.6%-27.9%+518.5%-7.0%+2671.0%

FOLD Depreciation and amortization History

DateAnnualQuarterlyTTM
Mar 2025
-
$1.84M(-10.0%)
$8.23M(-3.7%)
Dec 2024
$8.55M(+8.6%)
$2.04M(-5.9%)
$8.55M(-1.6%)
Sep 2024
-
$2.17M(-0.5%)
$8.69M(-0.7%)
Jun 2024
-
$2.18M(+1.3%)
$8.75M(-0.3%)
Mar 2024
-
$2.15M(-1.3%)
$8.77M(+11.4%)
Dec 2023
$7.87M(+47.4%)
$2.18M(-2.1%)
$7.87M(+12.4%)
Sep 2023
-
$2.23M(+1.0%)
$7.00M(+15.5%)
Jun 2023
-
$2.21M(+75.5%)
$6.06M(+16.8%)
Mar 2023
-
$1.26M(-4.1%)
$5.19M(-2.9%)
Dec 2022
$5.34M(-14.0%)
$1.31M(+1.9%)
$5.34M(-3.7%)
Sep 2022
-
$1.29M(-3.6%)
$5.55M(-4.0%)
Jun 2022
-
$1.33M(-5.5%)
$5.78M(-3.9%)
Mar 2022
-
$1.41M(-7.0%)
$6.02M(-3.1%)
Dec 2021
$6.21M(-29.8%)
$1.52M(-0.1%)
$6.21M(-14.2%)
Sep 2021
-
$1.52M(-3.0%)
$7.24M(-11.9%)
Jun 2021
-
$1.57M(-2.3%)
$8.21M(-5.4%)
Mar 2021
-
$1.60M(-37.0%)
$8.69M(-1.8%)
Dec 2020
$8.85M(+85.3%)
$2.55M(+2.0%)
$8.85M(+13.2%)
Sep 2020
-
$2.50M(+22.4%)
$7.81M(+21.5%)
Jun 2020
-
$2.04M(+15.6%)
$6.43M(+16.0%)
Mar 2020
-
$1.76M(+16.5%)
$5.55M(+16.2%)
Dec 2019
$4.78M(+13.3%)
$1.51M(+35.7%)
$4.78M(+7.0%)
Sep 2019
-
$1.12M(-3.3%)
$4.46M(+1.0%)
Jun 2019
-
$1.15M(+16.4%)
$4.42M(+4.3%)
Mar 2019
-
$991.00K(-17.5%)
$4.24M(+0.5%)
Dec 2018
$4.22M(+17.3%)
$1.20M(+11.9%)
$4.22M(+2.3%)
Sep 2018
-
$1.07M(+10.3%)
$4.12M(+5.7%)
Jun 2018
-
$973.00K(+0.4%)
$3.90M(+4.3%)
Mar 2018
-
$969.00K(-12.5%)
$3.74M(+4.1%)
Dec 2017
$3.59M(+10.8%)
$1.11M(+30.2%)
$3.59M(+5.9%)
Sep 2017
-
$850.00K(+4.6%)
$3.39M(-1.3%)
Jun 2017
-
$813.00K(-1.2%)
$3.44M(+1.4%)
Mar 2017
-
$823.00K(-9.2%)
$3.39M(+4.6%)
Dec 2016
$3.24M(+76.9%)
$906.00K(+1.1%)
$3.24M(+11.3%)
Sep 2016
-
$896.00K(+16.8%)
$2.91M(+20.8%)
Jun 2016
-
$767.00K(+14.0%)
$2.41M(+20.7%)
Mar 2016
-
$673.00K(+16.6%)
$2.00M(+9.0%)
DateAnnualQuarterlyTTM
Dec 2015
$1.83M(+18.5%)
$577.00K(+46.1%)
$1.83M(+13.1%)
Sep 2015
-
$395.00K(+11.9%)
$1.62M(+1.3%)
Jun 2015
-
$353.00K(-30.5%)
$1.60M(-2.6%)
Mar 2015
-
$508.00K(+39.6%)
$1.64M(+6.2%)
Dec 2014
$1.55M(-10.0%)
$364.00K(-2.9%)
$1.55M(-2.3%)
Sep 2014
-
$375.00K(-5.3%)
$1.58M(-3.3%)
Jun 2014
-
$396.00K(-3.9%)
$1.64M(-3.2%)
Mar 2014
-
$412.00K(+2.7%)
$1.69M(-1.6%)
Dec 2013
$1.72M(+0.8%)
$401.00K(-6.5%)
$1.72M(-1.2%)
Sep 2013
-
$429.00K(-4.7%)
$1.74M(+0.4%)
Jun 2013
-
$450.00K(+2.5%)
$1.73M(+0.5%)
Mar 2013
-
$439.00K(+4.3%)
$1.72M(+1.1%)
Dec 2012
$1.71M(+7.6%)
$421.00K(-0.2%)
$1.71M(+4.9%)
Sep 2012
-
$422.00K(-4.5%)
$1.63M(+2.7%)
Jun 2012
-
$442.00K(+5.2%)
$1.58M(+1.0%)
Mar 2012
-
$420.00K(+22.8%)
$1.57M(-1.1%)
Dec 2011
$1.58M(-23.0%)
$342.00K(-9.8%)
$1.58M(-8.1%)
Sep 2011
-
$379.00K(-11.0%)
$1.72M(-7.1%)
Jun 2011
-
$426.00K(-2.7%)
$1.86M(-5.3%)
Mar 2011
-
$438.00K(-8.9%)
$1.96M(-4.8%)
Dec 2010
$2.06M(-3.5%)
$481.00K(-5.9%)
$2.06M(-3.1%)
Sep 2010
-
$511.00K(-3.6%)
$2.12M(-2.3%)
Jun 2010
-
$530.00K(-1.1%)
$2.17M(+0.5%)
Mar 2010
-
$536.00K(-2.0%)
$2.16M(+1.5%)
Dec 2009
$2.13M(+42.8%)
$547.00K(-2.5%)
$2.13M(+4.4%)
Sep 2009
-
$561.00K(+8.1%)
$2.04M(+9.5%)
Jun 2009
-
$519.00K(+2.8%)
$1.86M(+11.2%)
Mar 2009
-
$505.00K(+10.5%)
$1.68M(+12.3%)
Dec 2008
$1.49M(+20.7%)
$457.00K(+19.3%)
$1.49M(+10.7%)
Sep 2008
-
$383.00K(+15.4%)
$1.35M(+5.3%)
Jun 2008
-
$332.00K(+3.4%)
$1.28M(+1.6%)
Mar 2008
-
$321.00K(+2.6%)
$1.26M(+1.9%)
Dec 2007
$1.24M(+29.9%)
$313.00K(-0.6%)
$1.24M(+33.9%)
Sep 2007
-
$315.00K(+1.0%)
$924.00K(+51.7%)
Jun 2007
-
$312.00K(+5.1%)
$609.00K(+105.1%)
Mar 2007
-
$297.00K
$297.00K
Dec 2006
$952.00K(+42.6%)
-
-
Dec 2005
$667.40K
-
-

FAQ

  • What is Amicus Therapeutics annual depreciation & amortization?
  • What is the all time high annual D&A for Amicus Therapeutics?
  • What is Amicus Therapeutics annual D&A year-on-year change?
  • What is Amicus Therapeutics quarterly depreciation & amortization?
  • What is the all time high quarterly D&A for Amicus Therapeutics?
  • What is Amicus Therapeutics quarterly D&A year-on-year change?
  • What is Amicus Therapeutics TTM depreciation & amortization?
  • What is the all time high TTM D&A for Amicus Therapeutics?
  • What is Amicus Therapeutics TTM D&A year-on-year change?

What is Amicus Therapeutics annual depreciation & amortization?

The current annual D&A of FOLD is $8.55M

What is the all time high annual D&A for Amicus Therapeutics?

Amicus Therapeutics all-time high annual depreciation & amortization is $8.85M

What is Amicus Therapeutics annual D&A year-on-year change?

Over the past year, FOLD annual depreciation & amortization has changed by +$674.00K (+8.56%)

What is Amicus Therapeutics quarterly depreciation & amortization?

The current quarterly D&A of FOLD is $1.84M

What is the all time high quarterly D&A for Amicus Therapeutics?

Amicus Therapeutics all-time high quarterly depreciation & amortization is $2.55M

What is Amicus Therapeutics quarterly D&A year-on-year change?

Over the past year, FOLD quarterly depreciation & amortization has changed by -$317.00K (-14.72%)

What is Amicus Therapeutics TTM depreciation & amortization?

The current TTM D&A of FOLD is $8.23M

What is the all time high TTM D&A for Amicus Therapeutics?

Amicus Therapeutics all-time high TTM depreciation & amortization is $8.85M

What is Amicus Therapeutics TTM D&A year-on-year change?

Over the past year, FOLD TTM depreciation & amortization has changed by -$540.00K (-6.16%)
On this page